Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

Conditions

• Gastric Cancer
• Gastroesophageal-junction Cancer

Interventions

• DRUG: Tislelizumab
• DRUG: S-1
• DRUG: Oxaliplatin
• DRUG: Nab paclitaxel
• RADIATION: Radiation

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School